TriSalus Life Sciences Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +44.5% | -14.2% | +71.9% | +8.8% | -15.9% | |
| – | +395.5% | +237.6% | +281.0% | +288.1% | +67.8% | |
| – | – | – | -76.7% | -1,878.2% | – | |
| – | +130.8% | -37.5% | -25.2% | -41.3% | +166.1% | |
| – | – | -20.9% | -11.1% | -78.3% | +142.9% | |
| – | – | – | – | – | – | |
| – | – | -89.9% | -33.6% | – | -60.2% | |
| – | -79.9% | -73.5% | +305.8% | -30.6% | -18.9% | |
| – | – | -179.9% | – | -232.0% | – | |
| – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.